Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
796 results about "Colonization" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Colonization (or colonisation) is a process by which a central system of power dominates the surrounding land and its components. Colonization refers strictly to migration, for example, to settler colonies in America or Australia, trading posts, and plantations, while colonialism to the existing indigenous peoples of styled "new territories". Colonization was linked to the spread of tens of millions from Western European states all over the world. In many settled colonies, Western European settlers eventually formed a large majority of the population after killing or driving away indigenous peoples. Examples include the Americas, Australia and New Zealand. These colonies were occasionally called 'neo-Europes'. In other places, Western European settlers formed minority groups, which often used more advanced weaponry to dominate the people initially living in their places of settlement.
Adhesin as immunogen against enterotoxigenic Escherichia coli
ActiveUS20060153878A1Inhibition of colonizationAvoid stickingAntibacterial agentsPeptide/protein ingredientsEscherichia coliDiarrhea
The inventive subject matter relates to the methods for the induction of immunity and prevention of diarrhea resulting from Escherichia coli. The inventive subject matter also relates to the use Escherichia coli adhesins as immunogens and to the construction of conformationally stability and protease resistant Escherichia coli adhesin constructs useful for inducing immunity to Escherichia coli pathogenic bacteria. The methods provide for the induction of B-cell mediated immunity and for the induction of antibody capable of inhibiting the adherence and colonization of Escherichia coli including enterotoxigenic Escherichia coli, to human cells.
Owner:THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY
Probiotic, lactic acid-producing bacteria and uses thereof
InactiveUS20060099197A1Good curative effectMitigating deleterious side-effectsAntibacterial agentsBiocideMicrobial agentAnti fungal
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid—producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds. The present invention also discloses methodologies for: (i) the selective breeding and isolation of probiotic, lactic acid-producing bacterial strains which possess resistance or markedly decreased sensitivity to anti-microbial agents (e.g., antibiotics, anti-fungal agents, anti-yeast agents, and anti-viral agents); and (ii) treating or preventing bacteria-mediated infections of the gastrointestinal tract by use of the aforementioned probiotic bacterial strains with or without the concomitant administration of antibiotics. While the primary focus is on the treatment of gastrointestinal tract infections, the therapeutic compositions of the present invention may also be administered to buccal, vaginal, optic, and like physiological locations.
Owner:GANEDEN BIOTECH
Medical Scaffold, Methods of Fabrication and Using Thereof
Articles of manufacturing comprising electrospun elements having continuous or stepwise gradients of porosity, average pore size, weight per volume and / or of agents for promoting cell colonization, differentiation, extravasation and / or migration are provided. Also provided are methods of manufacturing and using same for guiding tissue regeneration.
Owner:TECHNION RES & DEV FOUND LTD
Macroporous, resorbable and injectible calcium phosphate-based cements (MCPC) for bone repair, augmentation, regeneration, and osteoporosis treatment
ActiveUS20050199156A1Easy to controlSurgical adhesivesOther chemical processesApatitePhosphoric acid
A composition and method for producing interconnective macroporous, resorbable and injectable calcium phosphate-based cements (MICPCs). The composition of the invention sets to poorly crystalline apatitic calcium phosphate after mixing a powder component and an aqueous solution. The multiphasic calcium phosphate components in the cement resorb at different rates allowing the timely replacement by new bone. The interconnected macroporosity in the cement allows for vascularization, entrapment of growth factors, cell colonization and tissue ingrowth. This MICPC can be used for dental and medical applications relating to bone repair, augmentation, reconstruction, regeneration, and osteoporosis treatment, and also for drug delivery, and as scaffolds for tissue engineering.
Owner:INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +2
Streptococcal C5a peptidase vaccine
Owner:RGT UNIV OF MINNESOTA
Endophyte enhanced seedlings with increased pest tolerance
ActiveUS8455395B2Improve toleranceInoculation is highBiocideFungiIncreased toleranceFungal endophyte
The invention provides methods for preparing a conifer seedling with increased tolerance to a pest. A conifer seedling is inoculated with an isolated endophyte when the conifer seedling is susceptible to colonization by the endophyte.
Owner:J D IRVING
Antimicrobial adhesion surface
InactiveUS6468649B1Limit inhibit adhesionLimiting microbial adherenceSynthetic resin layered productsSurgeryHydrophilic coatingIn vivo
The present invention provides an implantable medical device having a substrate with a hydrophilic coating composition to limit in vivo colonization of bacteria and fungi. The hydrophilic coating composition includes a hydrophilic polymer with a molecular weight in the range from about 100,000 to about 15 million selected from copolymers acrylic acid, methacrylic acid, isocrotonic acid and combinations thereof.
Owner:BOSTON SCI SCIMED INC
Probiotic, lactic acid-producing bacteria and uses thereof
InactiveUS7708988B2Good curative effectMitigating deleterious side-effectsAntibacterial agentsBiocideDiseaseMicrobial agent
Owner:GANEDEN BIOTECH
Polymer coatings containing phytochemical agents and methods for making and using same
InactiveUS20080175812A1Reduce and destroy foulingGrowth inhibitionBiocideAntifouling/underwater paintsPhytochemicalControl release
This invention relates to compositions comprising a polymer base incorporating antifouling compositions suitable for use in aquaculture, marine and architectural systems as paints, structures or coatings. In particular, the present invention relates to a polymer based coating incorporating a biocidal antifouling composition suitable for use with aquaculture equipment. The present invention provides polyethylene compositions and latex compounds which may comprise at least one environmentally benign phytochemicals suitable for use in preventing the colonization of a treated surface by a variety of biological species. The compositions of the invention may further comprise control release agents such as, for example, micro-encapsulation of the phytochemicals to maintain sustained and prolonged release of the biocidal agents at the treated surface.
Owner:MAGELLAN
Production method of pig feed additive containing traditional Chinese medicine and active probiotics
ActiveCN102366024AEnhance colonization abilityImprove immunityAnimal feeding stuffDiseaseGrowth promoting
The invention discloses a production method of a pig feed additive containing traditional Chinese medicine and active probiotics, which comprises the steps of: respectively conducting single-spawn strain quantity expanding culture to the parent strains of active probiotics for pigs; mixing equiponderant first-order seed liquid of all kinds of active probiotics for pigs, inoculating the liquid into seed tank culture mediums for multi-spawn mixed culture and then inoculating the liquid into traditional Chinese medicine liquid culture mediums for primary traditional Chinese medicine fermentation; and mixing multi-spawn mixed traditional Chinese medicine fermentation liquid with corn cob meal with the same volume to obtain solid fermented seeds and then inoculating the seeds into traditional Chinese medicine solid culture mediums for secondary traditional Chinese medicine fermentation. By implementing the embodiment of the invention, the strain activity of the active probiotics in the pigfeed additive and the colonization performance in intestinal canals can be greatly improved, the produced pig feed additive is rich in traditional Chinese medicine compositions, the effect of active compositions which take a pharmacological effect in the traditional Chinese medicine compositions can be fully exerted, the body strengthening and disease curing performance and the growth promoting performance of the pig feed additive are improved and therefore the use of antibiotics can be fully avoided.
Owner:华林(辽宁)生物科技有限公司
Antimicrobial injection port barrier cover
InactiveUS20120078203A1Low costAvoid problemsMedical devicesIntravenous devicesInjection portCatheter
The invention relates to sterile medical injection catheter ports utilizing a new antimicrobial polymer mixture filled injection port barrier cover. This barrier cover, when screwed onto the injection port, protects the injection port from the colonization of microbes from the inadvertent contamination of the port with contaminated surfaces, including skin and other potential contaminants.
Owner:GAUBE GARY J +1
Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
InactiveUS20110200655A1Inhibition of colonizationReduce the prevalenceBiocidePowder deliveryWound dressingMedical product
A medical product is provided that is selected from at least one of, nasal cannulas, oxygen masks, wound dressings, bandages, band aids, catheters, endotrachial tubes, condoms, surgical and other gloves, sheaths for endoscopy probes, and medical products that physically touch the body. A coating is included with at least one of, a non-antibiotic, antimicrobial and / or antiviral substance that prevents further local, non-systemic, colonization of infections.
Owner:BLACK MICHAEL DARRYL +1
Fibronectin binding protein compositions and methods of use
InactiveUS6685943B1Avoid problemsOvercomes drawbackPeptide/protein ingredientsAntibody mimetics/scaffoldsPassive ImmunizationsStreptococcus pyogenes
Disclosed are antibodies that block the binding of fibronectin protein to fibronectin. Also disclosed are site specifically-mutated and truncated peptide epitopes derived from the fnbA and fnbB genes of Staphylococcus aureus, the fnba and fnbB genes of Streptococcus dysgalactiae, and the sfb gene of Streptococcus pyogenes, and nucleic acid segments encoding these peptides and epitopes. The anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin, and DNA segments encoding these proteins and are of use in various screening, diagnostic and therapeutic applications including active and passive immunization and methods for the prevention of streptococcal and staphylococcal colonization in animals or humans. These. DNA segments and the peptides derived therefrom are proposed to be of use directly in the preparation of vaccines and also for use as carrier proteins in vaccine formulations.
Owner:UNIVERSITY OF MANITOBA +2
Aeroponic plant growing system
An aeroponic plant growing system includes a water reservoir and growing chambers for growing plants in an aeroponic environment. A pump, a water distribution manifold, and water lines are used to provide water and nutrients from the water reservoir to sprayers in the growing chambers where the water and nutrients are sprayed on the roots of plants growing therein. The water distribution manifold and water lines preferably are provided as closed loop systems, such that water is provided to all sprayers despite a blockage in the manifold or a water line. Non-absorbed water and nutrients are returned to the water reservoir from the growing chambers on water return lines via a filter that includes multiple types of filter media, including filter media that support the colonization of organisms that support plant growth.
Owner:WALHOVD ZACK ALLEN
Macroporous, resorbable and injectible calcium phosphate-based cements (MCPC) for bone repair, augmentation, regeneration, and osteoporosis treatment
ActiveUS7351280B2Easy to controlSurgical adhesivesOther chemical processesOsteopoikilosisOsteoporosis treatment
A composition and method for producing interconnective macroporous, resorbable and injectable calcium phosphate-based cements (MICPCs). The composition of the invention sets to poorly crystalline apatitic calcium phosphate after mixing a powder component and an aqueous solution. The multiphasic calcium phosphate components in the cement resorb at different rates allowing the timely replacement by new bone. The interconnected macroporosity in the cement allows for vascularization, entrapment of growth factors, cell colonization and tissue ingrowth. This MICPC can be used for dental and medical applications relating to bone repair, augmentation, reconstruction, regeneration, and osteoporosis treatment, and also for drug delivery, and as scaffolds for tissue engineering.
Owner:INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +2
Probiotic, lactic acid-producing bacteria and uses thereof
InactiveUS20080233104A1Good curative effectMitigating deleterious side-effectsAntibacterial agentsAntimycoticsDiseaseMicrobial agent
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid-producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds. The present invention also discloses methodologies for: (i) the selective breeding and isolation of probiotic, lactic acid-producing bacterial strains which possess resistance or markedly decreased sensitivity to anti-microbial agents (e.g., antibiotics, anti-fungal agents, anti-yeast agents, and anti-viral agents); and (ii) treating or preventing bacteria-mediated infections of the gastrointestinal tract by use of the aforementioned probiotic bacterial strains with or without the concomitant administration of antibiotics. While the primary focus is on the treatment of gastrointestinal tract infections, the therapeutic compositions of the present invention may also be administered to buccal, vaginal, optic, and like physiological locations.
Owner:GANEDEN BIOTECH
Paints, coatings and polymers containing phytochemical agents and methods for making and using same
The present invention provides safe paint and coating compositions comprising at least one environmentally acceptable phytochemical such as, but not limited to capsicum, grapefruit seed extract and menthol suitable for use in preventing the colonization of a treated surface by a variety of biological species. One aspect of the invention is anti-fouling marine paints (coatings). Another aspect of the invention of the present invention provides paint and coating compositions comprising phytochemicals for use as an architectural paint. The compositions of the invention can further comprise control release agents such as, for example, antioxidants, oxidizers or photosensitive compounds to promote sustained release of the anti-colonization agents at the treated surface and to assist in the abrasion of the paint surface to mechanically dislodge the attaching organisms.
Owner:SEABROOK SAMUEL G JR
Method for preparing cow feed additive containing traditional Chinese medicine active probiotics
ActiveCN102366023AEnhance colonization abilityImprove immunityAnimal feeding stuffWorking-up animal fodderDiseaseLiquid medium
The invention discloses a method for preparing a cow feed additive containing traditional Chinese medicine active probiotics, comprising the following steps: respectively carrying out amplification culture of the strain number of a single bacterial specie on original strains of active probiotics for cows; mixing primary seed liquors of active probiotics for cows with same weight, inoculating the mixture in a seed tank medium to carry out multiple-strain mixed culture, then inoculating in a traditional Chinese medicine liquid medium to carry out a primary traditional Chinese medicine fermentation; and mixing the multiple-strain mixed traditional Chinese medicine fermentation liquor with isometric cob powder to obtain solid fermentation seeds, and then inoculating in a traditional Chinese medicine solid medium to carry out a secondary traditional Chinese medicine fermentation. According to the invention, the strain activity and colonization performance in the intestinal tracts of activeprobiotics in the cow feed additive are improved greatly, the prepared cow feed additive is rich in traditional Chinese medicine components, the active components with pharmacological effects in the traditional Chinese medicine components fully play the role, thus the performances of strengthening the body, treating diseases and promoting growth of the cow feed additive are improved, and furthermore completely displace antibiotics.
Owner:辽宁后金生物科技有限公司
Reduction in bacterial colonization by administering bacteriophage compositions
InactiveUS7459272B2Reduce and eliminate colonizationReduce riskAntibacterial agentsBiocideBacteroidesAcquired immunodeficiency
The present invention provides a method for reducing the risk of bacterial infection or sepsis in a susceptible patient by treating the susceptible patient with a pharmaceutical composition containing bacteriophage of one or more strains which produce lytic infections in pathogenic bacteria. Preferably, treatment of the patient reduces the level of colonization with pathogenic bacteria susceptible to the bacteriophage by at least one log. In a typical embodiment, the susceptible patient is an immunocompromised patient selected from the group consisting of leukemia patients, lymphoma patients, carcinoma patients, sarcoma patients, allogeneic transplant patients, congenital or acquired immunodeficiency patients, cystic fibrosis patients, and AIDS patients. In a preferred mode, the patients treated by this method are colonized with the pathogenic bacteria subject to infection by said bacteriophage.
Owner:INTRALYTIX
Antimicrobial compounds and compositions, and uses thereof
ActiveUS20160066578A1Improve growth performanceDecrease mortality adjusted feed conversion ratioCosmetic preparationsOrganic active ingredientsBenzoic acidMicrobial agent
A method of enhancing the growth of an animal is provided. The method includes causing the animal to ingest or absorb an effective amount of one or more Fe III complex compounds, including but not limited to Fe III complexes comprising ligands bound to the iron centre selected from amino acids or α-hydroxy acids, o-hydroxy benzoic acids or pyridine-2-carboxylic acids, such as ferric quinate, ferric tyrosine, ferric DOPA and ferric phenylalanine. Compounds which are structural and / or functional variants, derivatives and / or analogs of the foregoing compounds, as further described herein are also disclosed. Methods for inhibiting, reducing, or preventing biofilm formation or buildup on a surface; the treatment of, inhibition of growth of, and inhibition of colonization by, bacteria, both in biological and non-biological environments; disinfecting surfaces, potentiating the effects of antibiotics and other anti-microbial agents, and increasing the sensitivity of bacteria and other microorganisms, to anti-microbial agents are also provided.
Owner:AKESO BIOMEDICAL
Method, composition, and delivery mode for treatment of prostatitis and other urogenital infections using a probiotic rectal suppository
This invention is a probiotic composition using the delivery mode of a rectal suppository for the treatment and relief of symptoms of urogenital infections including prostatitis. This invention is unique in both mode of delivery and in enabling the treatment of such urogenital infections as prostatitis. The present invention discloses compositions, methodologies, and delivery mode for the utilization of probiotic organisms in therapeutic compositions for treatment and relief from the symptoms of urogenital infections by maintaining and restoring normal flora in humans. The composition includes one or more bacteria selected from the genus Lactobacillus. More specifically, the invention relates to the utilization of one or more species or strains of Lactobacillus producing bacteria for the control of urinary tract bacteria and pathogens, including antibiotic-resistant urinary tract pathogens, and their associated diseases by both a reduction in the rate of colonization of the infection and pathogens. The method for treatment and relief from symptoms includes administration via a rectal suppository with a safe and effective amount of the composition. The delivery mode for administering the probiotic is via a rectal suppository. The delivery through the rectum provides an optimum method of transmission of the treatment.
Owner:NESSA JEFFREY +1
Use of synergistic microorganisms and nutrients to produce signals that facilitate the germination and plant root colonization of mycorrhizal fungi in phosphorus rich environments
Owner:NOVOZYMES BIOAG AS
Plant culturing equipment
InactiveUS20140144079A1Control speedSimple materialAgriculture gas emission reductionCultivating equipmentsCulture fluidEngineering
A plant culturing equipment is composed of a plurality of planting walls, a plurality of lamp racks and a circulation fluid supply component, wherein the planting walls are mutually disposed in parallel, and the lamp rack is disposed relative to the planting walls to supply light source to the colonization board. The circulation fluid supply component is composed of connecting a plurality of fluid supply members, a fluid collection member, a plurality of pipes and a motor so as to form a circulation loop for the culture fluid. The fluid supply member is disposed onto the colonization board and fastened to the planting walls. The culture fluid is circularly utilized to supply plants. The plants are illuminated by the light source of the lamp board to replace natural light so as to control the speed of growing plants. The colonization board is pulled and pushed by the first sliding component.
Owner:LIN MING TSUN
Composition and method for reducing the colonization of animal intestines by salmonella and other bacterial pathogens
InactiveUS6126961AReducing human pathogen colonizationSafe and economical reductionBiocideAnimal feeding stuffIntestinal structureBacteroides
An animal feed composition for reducing colonization of animal intestines by Salmonella and other bacterial pathogens, includes a polysaccharide containing cis-hydroxy sugar units or a derivative thereof, or the monosaccharide ribose or rhamnose, or a derivative thereof, and an animal feed. The polysaccharide cis-hydroxy sugar units may be one or more of mannose, a mannose derivative, galactose, a galactose derivative, galactomannans, galactosamine, fucose and arabinose. The polysaccharides may be incorporated into an animal feed in the form of a food gum or other biolpolymer.
Owner:AURUM CERTUS
Method for treating black-odor rivers and lakes with microbiological preparations
InactiveCN101555088AAchieve degradationImprove self-cleaning abilityMultistage water/sewage treatmentSustainable biological treatmentDecompositionSludge
The invention pertains to the technical field of environment protection, which provides a method for treating black-odor rivers and lakes with microbiological preparations and comprises the following steps of: (1) pre-treatment of the rivers or the lakes; (2) biofilm colonization treatment; (3) microorganism augmentation treatment by direct application; (4) water ecology recovery and oxidation reduction of reductive sludge at the bottom; and (5) protection and further improvement of water environment. The method for treating black-odor rivers and lakes with microbiological preparations employs a plurality of microbiological preparations to treat the black-odor rivers and lakes, realizes the decomposition of organic pollutants in the water body, improves water ecological balance, and oxidizes, and reduces the reductive sludge at the bottoms of the rivers and lakes.
Owner:李华林
Method for planting similarly-wild dendrobium
InactiveCN103609321AIncrease productivityGood natural growth characteristicsHorticultureEcological environmentLand resources
The invention discloses a method for planting similarly-wild dendrobium. The method for planting the similarly-wild dendrobium comprises the seedling screening step, the host selection step, the planting geographical climate condition selection step, the planting environment selection step, the planting environment optimization step, the colonization cultivation step and the planting management step. The ecological environment for planting of the dendrobium is accurately selected and optimized, three-dimensional large-scale planting of the dendrobium in a tea garden is achieved, chemical fertilizer or pesticides are not applied, independent occupation of land resources is not caused by planting, quality of dendrobium products can be greatly improved, and the planting technology is easy to learn, small in investment, low in cost and applicable to wide popularization and application.
Owner:XISHUANGBANNA YINHAI FULIN DENDROBIUM
Synergistic antimicrobial compositions and methods for reducing biofilm formation
The present invention provides novel compositions comprising: (a) a thiol-specific reagent and a cationic polypeptide or (b) a thiol-specific reagent and an iron-sequestering glyocoprotein; and uses thereof for the preparation of devices, and in particular medical devices, susceptible to colonization by biofilm forming bacteria.
Owner:KANE BIOTECH
Capsular polysaccharide adhesin antigen, preparation, purification and use
A substantially pure capsular exopolysaccharide adhesin of coagulaso-negative staphylococcal strains, and a general method to prepare such adhesins, are described. Vaccines composed of such adhesins, and uses of such adhesins to produce polyclonal and mono-clonal antibodies against such adhesins, are also disclosed. The adhesins are useful in coating polymeric medical materials to prevent colonization by coagulase-negative staphylococcal strains, and as a probe in selecting desirable polymeric medical materials. Such adhesin antibodies are useful in vivo to prevent infection by noso-comial coagulase-negative staphylococcal strains, in assays for the detection of such bacteria, in assays for the estimation of such adhesins in complex mixtures, and as an affinity chromatography matrix.
Owner:THE BRIGHAM & WOMEN S HOSPITAL INC
Synergistic antimicrobial compositions and methods for reducing biofilm formation
The present invention provides novel compositions comprising: (a) a thiol-specific reagent and a cationic polypeptide or (b) a thiol-specific reagent and an iron-sequestering glyocoprotein; and uses thereof for the preparation of devices, and in particular medical devices, susceptible to colonization by biofilm forming bacteria.
Owner:KANE BIOTECH
Methods of and compositions for inhibiting the proliferation of mammalian cells
A method of preventing, inhibiting and / or reversing cell motility, actin filament assembly or disassembly, proliferation, colonization, differentiation, accumulation and / or development of abnormal cells in a subject is disclosed. The method is effected by administering to the subject a therapeutically effective amount of a ribonuclease of the T2 family having actin binding activity.
Owner:YISSUM RES DEV CO OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com